Literature DB >> 17681144

Macrophage polarization and insulin resistance: PPARgamma in control.

Israel F Charo1.   

Abstract

Macrophages orchestrate an inflammatory response that contributes to glucose intolerance in diet-induced obesity and plaque instability in atherosclerosis. Within this heterogeneous group of cells are proinflammatory (M1) and anti-inflammatory (M2) macrophages. Recent work has identified the nuclear hormone receptor PPARgamma as a critical signaling molecule in determining macrophage phenotype in vitro and in adipose tissue. In the current issue of Cell Metabolism, Bouhlel et al. (2007) extend this paradigm to the vessel wall by showing that both M1 and M2 macrophages are present in atherosclerotic lesions and that activation of PPARgamma polarizes circulating blood monocytes to become M2 macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681144     DOI: 10.1016/j.cmet.2007.07.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  54 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection.

Authors:  Takashi Satoh; Osamu Takeuchi; Alexis Vandenbon; Koubun Yasuda; Yoshiaki Tanaka; Yutaro Kumagai; Tohru Miyake; Kazufumi Matsushita; Toshihiko Okazaki; Tatsuya Saitoh; Kiri Honma; Toshifumi Matsuyama; Katsuyuki Yui; Tohru Tsujimura; Daron M Standley; Kenji Nakanishi; Kenta Nakai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-08-22       Impact factor: 25.606

3.  β-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies.

Authors:  Giorgio Camilli; Mathieu Bohm; Alícia Corbellini Piffer; Rachel Lavenir; David L Williams; Benedicte Neven; Gilles Grateau; Sophie Georgin-Lavialle; Jessica Quintin
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

4.  Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation.

Authors:  J-H Kim; K W Park; E-W Lee; W-S Jang; J Seo; S Shin; K-A Hwang; J Song
Journal:  Cell Death Differ       Date:  2013-12-13       Impact factor: 15.828

5.  Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP.

Authors:  Nidhi Kapoor; Jianli Niu; Yasser Saad; Sanjay Kumar; Tatiana Sirakova; Edilu Becerra; Xiaoman Li; Pappachan E Kolattukudy
Journal:  J Immunol       Date:  2015-05-01       Impact factor: 5.422

6.  Epigenetic regulation of the alternatively activated macrophage phenotype.

Authors:  Makoto Ishii; Haitao Wen; Callie A S Corsa; Tianju Liu; Ana L Coelho; Ronald M Allen; William F Carson; Karen A Cavassani; Xiangzhi Li; Nicholas W Lukacs; Cory M Hogaboam; Yali Dou; Steven L Kunkel
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

Review 7.  Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.

Authors:  David L Morris
Journal:  Mol Endocrinol       Date:  2015-05-22

8.  Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice.

Authors:  S Fujisaka; I Usui; M Ikutani; A Aminuddin; A Takikawa; K Tsuneyama; A Mahmood; N Goda; Y Nagai; K Takatsu; K Tobe
Journal:  Diabetologia       Date:  2013-03-15       Impact factor: 10.122

9.  Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Authors:  Allison J Rao; Christophe Nich; Lakshmi S Dhulipala; Emmanuel Gibon; Roberto Valladares; Stefan Zwingenberger; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2012-12-05       Impact factor: 4.396

10.  An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy.

Authors:  G P Fadini; S Vigili de Kreutzenberg; E Boscaro; M Albiero; R Cappellari; N Kränkel; U Landmesser; A Toniolo; C Bolego; A Cignarella; F Seeger; S Dimmeler; A Zeiher; C Agostini; A Avogaro
Journal:  Diabetologia       Date:  2013-04-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.